Full Text View
Tabular View
No Study Results Posted
Related Studies
TBTC Study 26: Weekly RFP/INH for 3 mo. vs. Daily INH for 9 mo. for the Treatment of LTBI
This study is enrolling participants by invitation only.
Study NCT00023452   Information provided by Centers for Disease Control and Prevention
First Received: September 6, 2001   Last Updated: July 27, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Tuberculosis
More general conditions related to this trial
Actinomycetales Infections
Bacterial Infections
Gram-Positive Bacterial Infections
Mycobacterium Infections
Interventions listed in this trial
Isoniazid daily for 9 months
Additional drug interventions recognized in this trial
Isoniazid
Rifapentine
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Antibiotics, Antitubercular
Antilipemic Agents
Antimetabolites
Antitubercular Agents
Fatty Acid Synthesis Inhibitors
Leprostatic Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Centers for Disease Control and Prevention
Department of Veterans Affairs


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services